These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 10603732

  • 21. Antibiotic susceptibility in Streptococcus pneumoniae, Haemophilus influenzae and Streptococcus pyogenes in Pakistan: a review of results from the Survey of Antibiotic Resistance (SOAR) 2002-15.
    Zafar A, Hasan R, Nizamuddin S, Mahmood N, Mukhtar S, Ali F, Morrissey I, Barker K, Torumkuney D.
    J Antimicrob Chemother; 2016 May; 71 Suppl 1(Suppl 1):i103-9. PubMed ID: 27048578
    [Abstract] [Full Text] [Related]

  • 22. Susceptibilities to levofloxacin in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis clinical isolates from children: results from 2000-2001 and 2001-2002 TRUST studies in the United States.
    Karlowsky JA, Thornsberry C, Critchley IA, Jones ME, Evangelista AT, Noel GJ, Sahm DF.
    Antimicrob Agents Chemother; 2003 Jun; 47(6):1790-7. PubMed ID: 12760850
    [Abstract] [Full Text] [Related]

  • 23. Antimicrobial resistance among community-acquired pneumonia isolates in Europe: first results from the SENTRY antimicrobial surveillance program 1997. SENTRY Participants Group.
    Fluit AC, Schmitz FJ, Jones ME, Acar J, Gupta R, Verhoef J.
    Int J Infect Dis; 1999 Jun; 3(3):153-6. PubMed ID: 10460927
    [Abstract] [Full Text] [Related]

  • 24. [Antimicrobial susceptibility of community-acquired respiratory tract pathogens isolated from class B hospitals in China during 2013 and 2014].
    Sun H, Chen L, Chen X, Jia X, Li N, Liu W, Tong H, Xiang R, Zhang F, Zhao H, Zhang J, Xu Y.
    Zhonghua Jie He He Hu Xi Za Zhi; 2016 Jan; 39(1):30-7. PubMed ID: 26792053
    [Abstract] [Full Text] [Related]

  • 25. The Viriato Study: update of antimicrobial susceptibility data of bacterial pathogens from community-acquired respiratory tract infections in Portugal in 2003 and 2004.
    Melo-Cristino J, Santos L, Ramirez M, Grupo de Estudo Português de Bactérias Patogénicas Respiratórias.
    Rev Port Pneumol; 2006 Jan; 12(1):9-30. PubMed ID: 16572254
    [Abstract] [Full Text] [Related]

  • 26. In vitro activity of telithromycin compared with macrolides and fluoroquinolones against Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis.
    Küçükbasmaci O, Gönüllü N, Aktaş Z, Gürol D, Berkiten R.
    Int J Antimicrob Agents; 2003 Nov; 22(5):497-501. PubMed ID: 14602368
    [Abstract] [Full Text] [Related]

  • 27. Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States.
    Jorgensen JH, Doern GV, Maher LA, Howell AW, Redding JS.
    Antimicrob Agents Chemother; 1990 Nov; 34(11):2075-80. PubMed ID: 2127342
    [Abstract] [Full Text] [Related]

  • 28. Antibacterial resistance of community-acquired respiratory tract pathogens recovered from patients in Germany and activity of the Ketolide Telithromycin: results from the PROTEKT surveillance study (1999-2000).
    Reinert RR, Rodloff AC, Halle E, Baer W, Beyreiss B, Seifert H, Wichelhaus TA, Maass M, Mehl M.
    Chemotherapy; 2004 Jun; 50(3):143-51. PubMed ID: 15272227
    [Abstract] [Full Text] [Related]

  • 29. [Alexander Project--5 years in Poland].
    Hryniewicz W.
    Pol Merkur Lekarski; 2003 Jan; 14(79):5-8. PubMed ID: 12712818
    [Abstract] [Full Text] [Related]

  • 30. Antimicrobial susceptibility of community-acquired respiratory tract pathogens in North America in 1999-2000: findings of the PROTEKT surveillance study.
    Hoban D, Waites K, Felmingham D.
    Diagn Microbiol Infect Dis; 2003 Apr; 45(4):251-9. PubMed ID: 12729995
    [Abstract] [Full Text] [Related]

  • 31. In vitro activity of cefditoren and other comparators against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis causing community-acquired respiratory tract infections in China.
    Yang Q, Xu Y, Chen M, Wang H, Sun H, Hu Y, Zhang R, Duan Q, Zhuo C, Cao B, Liu Y, Yu Y, Sun Z, Chu Y.
    Diagn Microbiol Infect Dis; 2012 Jun; 73(2):187-91. PubMed ID: 22521692
    [Abstract] [Full Text] [Related]

  • 32. The Alexander Project 1996-1997: latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections.
    Felmingham D, Grüneberg RN.
    J Antimicrob Chemother; 2000 Feb; 45(2):191-203. PubMed ID: 10660501
    [Abstract] [Full Text] [Related]

  • 33. Antimicrobial susceptibility of lower respiratory tract pathogens in Great Britain and Ireland 1999-2001 related to demographic and geographical factors: the BSAC Respiratory Resistance Surveillance Programme.
    Reynolds R, Shackcloth J, Felmingham D, MacGowan A, BSAC Extended Working Party on Respiratory Resistance Surveillance.
    J Antimicrob Chemother; 2003 Dec; 52(6):931-43. PubMed ID: 14585865
    [Abstract] [Full Text] [Related]

  • 34. Antimicrobial activity of advanced-spectrum fluoroquinolones tested against more than 2000 contemporary bacterial isolates of species causing community-acquired respiratory tract infections in the United States (1999).
    Deshpande LM, Jones RN.
    Diagn Microbiol Infect Dis; 2000 Jun; 37(2):139-42. PubMed ID: 10863108
    [Abstract] [Full Text] [Related]

  • 35. Prevalence of antimicrobial resistance among respiratory tract isolates in Latin America: results from SENTRY antimicrobial surveillance program (1997-98).
    Sader HS, Gales AC, Granacher TD, Pfaller MA, Jones RN, SENTRY Study Group (Latin America).
    Braz J Infect Dis; 2000 Oct; 4(5):245-54. PubMed ID: 11063556
    [Abstract] [Full Text] [Related]

  • 36. In vitro activity of ABT-773 versus macrolides and quinolones against resistant respiratory tract pathogens.
    Dubois J, St -Pierre C.
    Diagn Microbiol Infect Dis; 2001 Oct; 40(1-2):35-40. PubMed ID: 11448561
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. The evolving threat of antibiotic resistance in Europe: new data from the Alexander Project.
    Schito GC, Debbia EA, Marchese A.
    J Antimicrob Chemother; 2000 Jul; 46 Suppl T1():3-9. PubMed ID: 10997593
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.